Tag: GPCR
Superluminal scores $60M to carry AI-designed obesity pill to clinic
Superluminal Medicines banks $60M to take its AI-designed MC4R obesity drug into Phase 1.
Superluminal Medicines banks $60M to take its AI-designed MC4R obesity drug into Phase 1.